Kymera Therapeutics (KYMR) Stock Chart & Stock Price History → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free KYMR Stock Alerts $34.95 -0.65 (-1.83%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Kymera Therapeutics Stock Price Performance5 Day Performance-0.40%1 Month Performance+2.88%3 Month Performance-9.50%6 Month Performance+79.88%Year-To-Date Performance+37.27%1 Year Performance+17.88% Receive KYMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… KYMR Stock Chart for Sunday, May, 19, 2024 KYMR Chart by TradingView Kymera Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$35.60$34.95-1.83%$35.69$34.55493,095 shs$2.14 billion05/16/2024$35.94$35.60-0.95%$36.02$34.76484,460 shs$2.18 billion05/15/2024$35.09$35.94+2.42%$36.91$35.21668,681 shs$2.21 billion05/14/2024$38.36$35.09-8.52%$39.63$34.151.03 million shs$2.15 billion05/13/2024$37.90$38.36+1.21%$39.02$37.91439,473 shs$2.35 billion05/10/2024$38.61$37.90-1.84%$38.93$37.66333,730 shs$2.33 billion Get the Latest News and Ratings for KYMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$38.50$38.61+0.29%$39.44$38.37450,442 shs$2.37 billion05/08/2024$38.44$38.50+0.16%$38.91$37.65453,270 shs$2.36 billion05/07/2024$38.30$38.44+0.37%$39.06$38.08331,904 shs$2.36 billion05/06/2024$37.40$38.30+2.41%$38.52$37.19424,667 shs$2.35 billion05/03/2024$36.30$37.40+3.03%$38.21$36.06529,366 shs$2.29 billion05/02/2024$36.24$36.30+0.17%$36.83$35.06502,668 shs$2.23 billion05/01/2024$33.62$36.24+7.79%$37.80$33.52637,582 shs$2.22 billion04/30/2024$34.66$33.62-3.00%$34.44$33.55481,501 shs$2.06 billion04/29/2024$33.37$34.66+3.87%$34.71$33.67428,514 shs$2.13 billion04/26/2024$33.35$33.37+0.06%$34.13$33.22452,363 shs$2.04 billion04/25/2024$35.21$33.35-5.28%$34.29$32.75786,230 shs$2.04 billion04/24/2024$35.71$35.21-1.40%$36.26$34.67379,566 shs$2.15 billion04/23/2024$34.35$35.71+3.96%$37.01$34.49437,028 shs$2.18 billion04/22/2024$33.97$34.35+1.12%$35.37$33.85417,209 shs$2.10 billion04/19/2024$35.12$33.97-3.27%$35.53$33.35627,418 shs$2.08 billion04/18/2024$33.76$35.12+4.03%$35.57$33.67619,727 shs$2.15 billion04/17/2024$33.93$33.76-0.50%$34.41$33.17433,664 shs$2.06 billion04/16/2024$34.39$33.93-1.34%$34.76$33.58492,320 shs$2.07 billion04/15/2024$35.58$34.39-3.34%$35.82$34.20528,658 shs$2.10 billion04/12/2024$37.21$35.58-4.38%$36.89$34.75598,099 shs$2.17 billion04/11/2024$35.33$37.21+5.32%$37.32$35.43469,853 shs$2.27 billion04/10/2024$37.61$35.33-6.06%$36.43$35.07655,350 shs$2.16 billion04/09/2024$36.37$37.61+3.41%$37.64$35.98494,947 shs$2.30 billion04/08/2024$36.40$36.37-0.08%$37.18$35.96296,256 shs$2.22 billion04/05/2024$36.24$36.40+0.44%$37.16$35.27428,984 shs$2.22 billion04/04/2024$37.13$36.24-2.40%$38.05$36.04471,912 shs$2.21 billion04/03/2024$37.64$37.13-1.35%$38.09$36.59591,871 shs$2.27 billion04/02/2024$39.42$37.64-4.52%$38.66$36.76543,257 shs$2.30 billion04/01/2024$40.20$39.42-1.94%$40.55$38.21528,318 shs$2.41 billion03/29/2024$40.20$40.20$40.62$39.34544,045 shs$2.46 billion03/28/2024$40.17$40.20+0.07%$40.62$39.35544,033 shs$2.46 billion03/27/2024$39.49$40.17+1.72%$40.21$38.96612,526 shs$2.45 billion03/26/2024$39.50$39.49-0.03%$40.36$38.99382,438 shs$2.41 billion03/25/2024$40.72$39.50-3.00%$41.33$39.28302,017 shs$2.41 billionBreaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story…03/22/2024$40.82$40.72-0.24%$41.30$39.99323,323 shs$2.49 billion03/21/2024$40.33$40.82+1.21%$41.89$40.42644,597 shs$2.49 billion03/20/2024$39.57$40.33+1.92%$40.42$38.75695,976 shs$2.46 billion03/19/2024$39.32$39.57+0.64%$40.30$38.781.67 million shs$2.42 billion03/18/2024$40.58$39.32-3.10%$41.24$39.081.01 million shs$2.40 billion03/15/2024$39.51$40.58+2.71%$41.50$39.132.01 million shs$2.48 billion03/14/2024$42.30$39.51-6.60%$42.26$39.23889,106 shs$2.41 billion03/13/2024$41.85$42.30+1.08%$43.10$41.50742,475 shs$2.59 billion03/12/2024$42.29$41.85-1.04%$43.07$41.34670,293 shs$2.56 billion03/11/2024$43.49$42.29-2.76%$44.14$42.10516,198 shs$2.58 billion03/08/2024$42.70$43.49+1.85%$44.23$42.32378,183 shs$2.66 billion03/07/2024$41.90$42.70+1.91%$43.57$41.51533,341 shs$2.61 billion03/06/2024$41.90$41.90$43.24$41.07534,171 shs$2.49 billion03/05/2024$42.60$41.90-1.64%$42.60$41.52389,867 shs$2.49 billion03/04/2024$43.50$42.60-2.07%$44.14$41.03517,264 shs$2.53 billion03/01/2024$42.70$43.50+1.87%$44.97$42.92713,057 shs$2.58 billion02/29/2024$43.25$42.70-1.27%$44.59$42.58633,277 shs$2.53 billion02/28/2024$43.57$43.25-0.73%$44.27$42.69496,593 shs$2.57 billion02/27/2024$43.44$43.57+0.30%$45.31$43.16806,402 shs$2.59 billion02/26/2024$41.84$43.44+3.82%$44.55$41.60828,267 shs$2.58 billion02/23/2024$40.49$41.84+3.33%$42.15$40.03700,005 shs$2.48 billion02/22/2024$38.67$40.49+4.71%$42.68$38.80858,728 shs$2.25 billion02/21/2024$38.03$38.67+1.68%$39.22$37.39524,014 shs$2.15 billion02/20/2024$38.62$38.03-1.53%$39.39$37.91442,268 shs$2.11 billion02/19/2024$38.62$38.62$38.86$36.81542,100 shs$2.14 billion Related Companies: VCEL Stock Chart DNLI Stock Chart CGON Stock Chart APGE Stock Chart SANA Stock Chart TWST Stock Chart RXRX Stock Chart DNA Stock Chart ACLX Stock Chart BEAM Stock Chart Receive KYMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KYMR) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsUrgent Nvidia WarningAltimetryCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kymera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.